benzofurans and cyclic-guanosine-monophosphate-adenosine-monophosphate

benzofurans has been researched along with cyclic-guanosine-monophosphate-adenosine-monophosphate* in 2 studies

Other Studies

2 other study(ies) available for benzofurans and cyclic-guanosine-monophosphate-adenosine-monophosphate

ArticleYear
Small molecule inhibition of human cGAS reduces total cGAMP output and cytokine expression in cells.
    Scientific reports, 2020, 05-05, Volume: 10, Issue:1

    The cGAS-STING pathway is a major mechanism that mammalian cells utilize to detect cytoplasmic dsDNA from incoming viruses, bacteria, or self. CYCLIC GMP-AMP SYNTHASE (cGAS) is the sensor protein that directly binds dsDNAs. cGAS synthesizes cyclic GMP-AMP (cGAMP), which binds to the adaptor STIMULATOR OF INTERFERON GENES (STING), activating an INTERFERON REGULATORY FACTOR 3 (IRF3)-mediated immune response. Constitutive activation can result in interferonopathies such as Aicardi-Goutieres Syndrome (AGS) or other lupus-like autoimmune disorders. While inhibitors targeting mouse or human cGAS have been reported, the identification of a small molecule that targets both homologs of cGAS has been challenging. Here, we show that RU.521 is capable of potently and selectively inhibiting mouse and human cGAS in cell lines and human primary cells. This inhibitory activity requires the presence of cGAS, but it cannot suppress an immune response in cells activated by RNA, Toll-like receptor ligands, cGAMP, or recombinant interferon. Importantly, when RU.521 is applied to cells, the production of dsDNA-induced intracellular cGAMP is suppressed in a dose-dependent manner. Our work validates the use of RU.521 for probing DNA-induced innate immune responses and underscores its potential as an ideal scaffold towards pre-clinical development, given its potency against human and mouse cGAS.

    Topics: Animals; Benzofurans; Cell Line; Cytokines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Humans; Immunomodulation; Membrane Proteins; Mice; Models, Biological; Monocytes; Nucleotides, Cyclic; Nucleotidyltransferases; Receptors, Pattern Recognition; Signal Transduction

2020
Structure of the Human cGAS-DNA Complex Reveals Enhanced Control of Immune Surveillance.
    Cell, 2018, 07-12, Volume: 174, Issue:2

    Cyclic GMP-AMP synthase (cGAS) recognition of cytosolic DNA is critical for immune responses to pathogen replication, cellular stress, and cancer. Existing structures of the mouse cGAS-DNA complex provide a model for enzyme activation but do not explain why human cGAS exhibits severely reduced levels of cyclic GMP-AMP (cGAMP) synthesis compared to other mammals. Here, we discover that enhanced DNA-length specificity restrains human cGAS activation. Using reconstitution of cGAMP signaling in bacteria, we mapped the determinant of human cGAS regulation to two amino acid substitutions in the DNA-binding surface. Human-specific substitutions are necessary and sufficient to direct preferential detection of long DNA. Crystal structures reveal why removal of human substitutions relaxes DNA-length specificity and explain how human-specific DNA interactions favor cGAS oligomerization. These results define how DNA-sensing in humans adapted for enhanced specificity and provide a model of the active human cGAS-DNA complex to enable structure-guided design of cGAS therapeutics.

    Topics: Animals; Benzofurans; Binding Sites; Catalytic Domain; Chemotaxis; DNA; Humans; Immunologic Surveillance; Mice; Molecular Docking Simulation; Mutagenesis, Site-Directed; Nucleotides, Cyclic; Nucleotidyltransferases; Protein Multimerization; Protein Structure, Tertiary; Recombinant Proteins; Species Specificity; Vibrio cholerae

2018